Tolylfluanid
CAS No.
731-27-1
Accumulation in bone and teeth
 
 

Return to Adverse Effects

EUROPEAN COMMISSION.
Final addendum to the Draft Assessment Report (DAR)
- public version -
Initial risk assessment provided by the rapporteur Member State Finland for the existing active substance
TOLYLFLUANID
of the second stage of the review programme referred to in Article 8(2) of Council Directive 91/414/EEC
February 2005

Excerpts

B.6.8.1.1 Subacute and subchronic studies

Table 6.8-1. Determination of fluoride in ashes from canine bone sections of dogs in a 52 week subchronic study by the oral route (Wetzig and Schilde, 1997). page 74

Tolyfluanid (mg/kg bw/day)
Milligram fluoride / g ash
Male dogs Female dogs
0 0.974 ± 0.245 0.879 ± 0.092
5 1.062 ± 0.229 0.955 ± 0.169
20 1.133 ± 0.075 1.111 ± 0.154 *
80 1.838 ± 0.162 * 1.587 ± 0.191 *
* p < 0.05 (Mann-Whitney U test)

B.6.8.1.1 Subacute and subchronic studies

Table 6.8-2. Determination of fluoride in ashes from canine teeth of dogs in a 52 week subchronic study by the oral route (Wetzig and Schilde, 1997). page 74

Tolyfluanid (mg/kg bw/day)
Milligram fluoride / g ash
Male dogs Female dogs
0 0.444 ± 0.076 0.358 ± 0.091
5 0.464 ± 0.082 0.589 ± 0.155 *
20 0.519 ± 0.027 0.517 ± 0.085
80 0.771 ± 0.068 * 0.670 ± 0.099 *
* p < 0.05 (Mann-Whitney U test)

2-year rat study (Leser et al., 1996)

Table 6.8-3. Determination of fluoride in ashes from bone and teeth of rats in a 2-year chronic study by dietary administration (Leser et al. , 1996). Results after 53 weeks of administration of tolylfluanid. page 75

Tolyfluanid (ppm)
Milligram fluoride / g ash in bone
Males Females
0 0.414 0.648
60 0.529 0.761
300 0.886 1.223
1500 2.389* 3.148*
7500 4.721* 7.693*
 
Milligram fluoride / g ash in teeth
Males Females
0 0.123 0.146
60 0.168 0.192
300 0.335* 0.393
1500 0.745* 0.952*
7500 2.706* 3.557*
* p < 0.05 (Mann-Whitney U test)

2-year rat study (Leser et al., 1996)

Table 6.8-4. Determination of fluoride in ashes from bone and teeth of rats in a 2-year chronic study by dietary administration (Leser et al. , 1996). Results after 105 - 107 weeks of administration of tolylfluanid. page 75

Tolyfluanid (ppm and mg/kg bw/day)
Milligram fluoride / g ash in bone
Males Females
0 0.683 0.805
60 (3.6) 0.833 0.935  
300 (18.1) 1.326*   1.360*  
1500 (90.1) 3.289*   3.506*   
7500 (504.2) 9.698*   10.899*  
 
Milligram fluoride / g ash in teeth
Males Females
0 0.309 0.328
60 (4.2) 0.252 0.277
300 (21.1) 0.450 0.430
1500 (105.2) 1.097* 1.098*
7500 (584.4) 3.456* 3.822*  
* p < 0.05 (Mann-Whitney U test)

2-year mouse study (Leser and Ruehl-Fehlert, 1996)

Table 6.8-7. Determination of fluoride in ashes from bone and teeth of mice in a 2-year chronic study by dietary administration (Leser and Ruehl-Fehlert, 1996). Results after 54 weeks of administration of tolylfluanid. page 76

Tolyfluanid (ppm)
Milligram fluoride / g ash in bone
Males Females
0 1.107 0.926
60 1.200 1.089
300 1.777* 1.702*
1500 3.971* 3.167*
7500 9.936* 9.398*
 
Milligram fluoride / g ash in teeth
Males Females
0 0.258 0.250
60 0.312 0.292
300 0.517* 0.515
1500 1.205* 1.131*
7500 3.275* 3.595*
* p < 0.05 (Mann-Whitney U test)

2-year mouse study (Leser and Ruehl-Fehlert, 1996)

Table 6.8-8. Determination of fluoride in ashes from bone and teeth of mice in a 2-year chronic study by dietary administration (Leser and Ruehl-Fehlert, 1996). Results after 106 weeks of administration of tolylfluanid. page 77

Tolyfluanid (ppm and mg/kg bw/day)
Milligram fluoride / g ash in bone
Males Females
0 1.421 1.244
60 (15.3) 1.708 1.529*
300 (76.3) 2.465 2.427*
1500 (375.8) 5.492* 5.630*
7500 (2307.6) 10.862* 12.599*
 
Milligram fluoride / g ash in teeth
Males Females
0 0.398 0.452
60 (24.5) 0.513 0.498
300 (123.9) 1.004* 0.699
1500 (610.8) 1.860* 1.731*
7500 (2962.8) 5.192* 6.159*
* p < 0.05 (Mann-Whitney U test)

Intake of fluoride at exposure to tolylfluanid
Tolylfluanid contains about 6% fluorine as part of the molecule. If the ADI is set at 0.2 mg/kg bw/day, based on the 2-year dietary study in rat with a NOAEL of 18.1 – 21.1 mg/kg bw/day (SF = 100), then the highest acceptable amount of fluoride released from the molecule is about 0.012 mg/kg bw/day. Table 6.8-11 presents a calculation of the intake of tolylfluanid based on the currently supported MRL:s for commodities in the European diet (Heimann, 2002). page 74

The TMDI for tolylfluanid in the european diet is 0.017721 mg/kg bw/day. Assuming that the release of fluoride is 6% of the mass of tolylfluanid, then the expected intake of fluoride from tolylfluanid treated food commodities is about 0.0011 mg/kg bw/day. In assessing the extent of exposure to fluoride released from tolylfluanid in consumers, all possible exposure sources must be considered. The main source for fluoride in most countries is direct consumption of drinking water. Food commodities are also a major source for fluoride intake in consumers. The WHO guideline for a maximum level of fluoride in water is 1.5 mg/litre (WHO, 1994). The UK Medical Research Council (MRC, 2002) has concluded that there is a risk for dental fluorosis in children at drinking water fluoride levels ≥2 mg/l. In areas where the natural levels of fluoride in water are low, the recommended maximum addition of fluoride in the form of tablets to prevent dental caries is 1.5 mg per day. Provided that the maximum allowable daily intake of fluoride from all sources should not exceed 1.5 mg per person, to avoid fluorosis, the allowable intakes as mg/kg bw/day for different age groups (addults 70 kg and children 20 kg bw) vary between 0.02 and 0.08 mg/kg bw/day. If the total recommendable intake of fluoride in humans from all sources should not exceed 0.02 mg/kg bw/day, the addition of fluoride from tolylfluanid in the diet would contribute at most to about 5% of the total amount fluoride that can be safely ingested per day. page 79

Summary of possible health effects of fluoride released from tolylfluanid

In rats, at life-time ingestion of tolylfluanid, fluoride levels in bone increased from 0.683 – 0.805 mg/g ash in controls to about 1.3 mg/g ash at a dose of about 20 mg/kg bw/day of tolylfluanid. In mice fluoride levels in bone increased from 1.244 – 1.421 mg/g ash in controls to 1.529 – 1.708 mg/g ash at a dose of >15 mg/kg bw/day. There is surprisingly little information about levels of fluoride in bones of humans in relation to ingested amounts, considering that the controversy over the benefits of fluoride supplementation of the diet has been going on now for at least 40 years. Weatherell (1966) reported that the amount of fluoride in bones of humans, in areas where drinking water contains less than 0.5 mg/l fluoride, increases with age. In the age group 20 – 30 years the range of fluoride concentrations in bone varied between 0.2 and 0.8 mg/g ash, and in the age group 70 – 80 years from 1.0 to 2.5 mg/g ash. A direct comparison with animal data is difficult, but at the highest recommended level of fluoride in water (1.5 mg/l) the concentrations of fluoride in bones of humans in these aereas may expected to be higher than 0.6 mg/g ash and even higher than 5.0 mg/g ash in different age groups. Skeletal anomalies in rats and mice occurred clearly at feeding levels higher than 100 mg/kg bw/day tolylfluanid, when concentrations of fluoride in bones were usually over 3.0 mg/g ash. The dietary intake assessment for tolylfluanid and the fluoride released from it show that the tolylfluanid residues in food contributes little to the total amount of fluoride ingested per day. Based on the animal studies and what is known about effects of fluoride in humans, the overall NOAEL:s for the 2-year rat study (about 20 mg/kg bw/day) and the 2-year mouse study (about 15 mg/kg bw/day) are approporiate also from the point of view of fluoride release from tolylfluanid and the likelyhood of fluorosis in humans at intake levels close to the ADI:s possibly set from these values. pages 79-80

 
Fluoride Action Network | Pesticide Project | 315-379-9200 | pesticides@fluoridealert.org